HEBEI SENLANG BIOTECHNOLOGY
Hebei Senlang Biotechnology is focused on the treatment of immune cells new technology development and application of high-tech enterprises.The company has the CAR-T research base (Senrang CAR-T Research Center) in North China, and has formed a high-barrier technology platform such as innovative CAR structural design, virus and cell culture , which can take into account technical research and development, hospital clinical application Provide high-quality and effective cellular immunotherapy support for hematological tumors, solid tumors and other tumor diseases, immune system diseases and other patients.
HEBEI SENLANG BIOTECHNOLOGY
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2016-01-01
Address:
Dongguan, Hebei, China
Country:
China
Website Url:
http://www.senlangbio.com
Status:
Active
Contact:
+86-311-82970975
Total Funding:
29.61 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Mobile Non Scaleable Content Nginx Amazon Apple Mobile Web App Capable DigiCert SSL Apple Mobile Web App Status Bar Style GeoTrust SSL Amazon California Region
Similar Organizations
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
Current Employees Featured
Founder
Investors List
Qianhai Fund of Funds
Qianhai Fund of Funds investment in Private Equity Round - Hebei Senlang Biotechnology
Guochuang Investment
Guochuang Investment investment in Series B - Hebei Senlang Biotechnology
Hebei Xianchuang
Hebei Xianchuang investment in Series B - Hebei Senlang Biotechnology
